Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Ubiquitin Immunostaining in Thyroid Neoplasms Marks True Intranuclear Cytoplasmic Pseudoinclusions and May Help Differentiate Papillary Carcinoma from NIFTP.

Cracolici V, Krausz T, Cipriani NA.

Head Neck Pathol. 2018 Mar 6. doi: 10.1007/s12105-018-0905-7. [Epub ahead of print]

PMID:
29512025
2.

Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.

Rosen LE, Karrison T, Ananthanarayanan V, Gallan AJ, Adusumilli PS, Alchami FS, Attanoos R, Brcic L, Butnor KJ, Galateau-Sallé F, Hiroshima K, Kadota K, Klampatsa A, Stang NL, Lindenmann J, Litzky LA, Marchevsky A, Medeiros F, Montero MA, Moore DA, Nabeshima K, Pavlisko EN, Roggli VL, Sauter JL, Sharma A, Sheaff M, Travis WD, Vigneswaran WT, Vrugt B, Walts AE, Tjota MY, Krausz T, Husain AN.

Mod Pathol. 2018 Apr;31(4):598-606. doi: 10.1038/modpathol.2017.170. Epub 2018 Jan 12.

PMID:
29327706
3.

PAX8 Expression in a Subset of Malignant Peritoneal Mesotheliomas and Benign Mesothelium has Diagnostic Implications in the Differential Diagnosis of Ovarian Serous Carcinoma.

Chapel DB, Husain AN, Krausz T, McGregor SM.

Am J Surg Pathol. 2017 Dec;41(12):1675-1682. doi: 10.1097/PAS.0000000000000935.

PMID:
28877056
4.

An Ovarian Adenocarcinoma With Combined Low-grade Serous and Mesonephric Morphologies Suggests a Müllerian Origin for Some Mesonephric Carcinomas.

Chapel DB, Joseph NM, Krausz T, Lastra RR.

Int J Gynecol Pathol. 2018 Sep;37(5):448-459. doi: 10.1097/PGP.0000000000000444.

PMID:
28863071
5.

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.

Husain AN, Colby TV, Ordóñez NG, Allen TC, Attanoos RL, Beasley MB, Butnor KJ, Chirieac LR, Churg AM, Dacic S, Galateau-Sallé F, Gibbs A, Gown AM, Krausz T, Litzky LA, Marchevsky A, Nicholson AG, Roggli VL, Sharma AK, Travis WD, Walts AE, Wick MR.

Arch Pathol Lab Med. 2018 Jan;142(1):89-108. doi: 10.5858/arpa.2017-0124-RA. Epub 2017 Jul 7.

PMID:
28686500
6.

Melanotic PEComa of the Sinonasal Mucosa With NONO-TFE3 Fusion: An Elusive Mimic of Sinonasal Melanoma.

McGregor SM, Alikhan MB, John RA, Kotler H, Bridge JA, Mujacic I, Kadri S, Segal J, Krausz T.

Am J Surg Pathol. 2017 May;41(5):717-722. doi: 10.1097/PAS.0000000000000778.

PMID:
28009605
7.

BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma.

McGregor SM, McElherne J, Minor A, Keller-Ramey J, Dunning R, Husain AN, Vigneswaran W, Fitzpatrick C, Krausz T.

Hum Pathol. 2017 Feb;60:86-94. doi: 10.1016/j.humpath.2016.09.026. Epub 2016 Oct 19.

PMID:
27771374
8.

Primary epithelioid sarcoma of the kidney and adrenal gland: report of 2 cases with immunohistochemical and molecular cytogenetic studies.

Alikhan MB, Pease G, Watkin W, Grogan R, Krausz T, Antic T.

Hum Pathol. 2017 Mar;61:158-163. doi: 10.1016/j.humpath.2016.09.024. Epub 2016 Oct 18.

PMID:
27769872
9.

Disseminated Malignant Rhabdoid Tumor of the Head and Neck.

Ginat DT, Cipriani NA, Purakal A, Fitzpatrick C, Paral K, Krausz T, Pytel P.

Head Neck Pathol. 2017 Jun;11(2):224-227. doi: 10.1007/s12105-016-0754-1. Epub 2016 Sep 8.

10.

A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer.

Nanda R, Stringer-Reasor EM, Saha P, Kocherginsky M, Gibson J, Libao B, Hoffman PC, Obeid E, Merkel DE, Khramtsova G, Skor M, Krausz T, Cohen RN, Ratain MJ, Fleming GF, Conzen SD.

Springerplus. 2016 Jun 30;5(1):947. doi: 10.1186/s40064-016-2457-1. eCollection 2016.

11.

Epigenetic regulation of SMARCB1 By miR-206, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas.

Sápi Z, Papp G, Szendrői M, Pápai Z, Plótár V, Krausz T, Fletcher CD.

Genes Chromosomes Cancer. 2016 Oct;55(10):786-802. doi: 10.1002/gcc.22379. Epub 2016 Jun 24.

PMID:
27223121
12.

MYC Amplification in Angiosarcoma Arising from an Arteriovenous Graft Site.

Paral KM, Raca G, Krausz T.

Case Rep Pathol. 2015;2015:537297. doi: 10.1155/2015/537297. Epub 2015 Nov 24.

13.

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.

McGregor SM, Dunning R, Hyjek E, Vigneswaran W, Husain AN, Krausz T.

Hum Pathol. 2015 Nov;46(11):1670-8. doi: 10.1016/j.humpath.2015.06.024. Epub 2015 Jul 21.

PMID:
26376834
14.

Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.

Frankenberger C, Rabe D, Bainer R, Sankarasharma D, Chada K, Krausz T, Gilad Y, Becker L, Rosner MR.

Cancer Res. 2015 Oct 1;75(19):4063-73. doi: 10.1158/0008-5472.CAN-14-3394. Epub 2015 Aug 3.

15.

Frequent FOS Gene Rearrangements in Epithelioid Hemangioma: A Molecular Study of 58 Cases With Morphologic Reappraisal.

Huang SC, Zhang L, Sung YS, Chen CL, Krausz T, Dickson BC, Kao YC, Agaram NP, Fletcher CD, Antonescu CR.

Am J Surg Pathol. 2015 Oct;39(10):1313-21. doi: 10.1097/PAS.0000000000000469.

16.

Melanocytic tumors with intraepidermal melanophages: a report of five cases with review of 231 archived cutaneous melanocytic tumors.

Fujimoto M, Basko-Plluska JL, Krausz T, Selim MA, Shea CR.

J Cutan Pathol. 2015 Jun;42(6):394-9. doi: 10.1111/cup.12479. Epub 2015 Mar 27.

PMID:
25733008
17.

Evaluation of clonal origin of malignant mesothelioma.

Comertpay S, Pastorino S, Tanji M, Mezzapelle R, Strianese O, Napolitano A, Baumann F, Weigel T, Friedberg J, Sugarbaker P, Krausz T, Wang E, Powers A, Gaudino G, Kanodia S, Pass HI, Parsons BL, Yang H, Carbone M.

J Transl Med. 2014 Dec 4;12:301. doi: 10.1186/s12967-014-0301-3.

18.

A Pilot Study of Galectin-3, HBME-1, and p27 Triple Immunostaining Pattern for Diagnosis of Indeterminate Thyroid Nodules in Cytology With Correlation to Histology.

Zhang L, Krausz T, DeMay RM.

Appl Immunohistochem Mol Morphol. 2015 Aug;23(7):481-90. doi: 10.1097/PAI.0000000000000106.

19.

Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder.

Paner GP, Cox RM, Richards K, Akki A, Gokden N, Lopez-Beltran A, Krausz T, McKenney JK, Steinberg GD.

Am J Surg Pathol. 2014 Sep;38(9):1251-9. doi: 10.1097/PAS.0000000000000241.

PMID:
25133708
20.

ZFP36-FOSB fusion defines a subset of epithelioid hemangioma with atypical features.

Antonescu CR, Chen HW, Zhang L, Sung YS, Panicek D, Agaram NP, Dickson BC, Krausz T, Fletcher CD.

Genes Chromosomes Cancer. 2014 Nov;53(11):951-9. doi: 10.1002/gcc.22206. Epub 2014 Jul 18.

21.

Effect of glatiramer acetate on peripheral blood brain-derived neurotrophic factor and phosphorylated TrkB levels in relapsing-remitting multiple sclerosis.

Vacaras V, Major ZZ, Muresanu DF, Krausz TL, Marginean I, Buzoianu DA.

CNS Neurol Disord Drug Targets. 2014;13(4):647-51.

PMID:
24938775
22.

Carbonic anhydrase IX (CAIX) does not differentiate between benign and malignant mesothelium.

Ananthanarayanan V, Tretiakova M, Husain AN, Krausz T, Antic T.

Am J Clin Pathol. 2014 Jul;142(1):82-7. doi: 10.1309/AJCP8BJ8CJXUEHZD.

PMID:
24926090
23.

How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study.

Husain AN, Mirza MK, Gibbs A, Hiroshima K, Chi Y, Boumendjel R, Stang N, Krausz T, Galateau-Salle F.

Lung Cancer. 2014 Mar;83(3):324-8. doi: 10.1016/j.lungcan.2013.12.009. Epub 2013 Dec 30.

PMID:
24440278
24.

SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on Both mRNA and protein levels.

Papp G, Krausz T, Stricker TP, Szendrői M, Sápi Z.

Genes Chromosomes Cancer. 2014 Feb;53(2):168-76. doi: 10.1002/gcc.22128. Epub 2013 Nov 5.

PMID:
24327545
25.

Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.

Antonescu CR, Le Loarer F, Mosquera JM, Sboner A, Zhang L, Chen CL, Chen HW, Pathan N, Krausz T, Dickson BC, Weinreb I, Rubin MA, Hameed M, Fletcher CD.

Genes Chromosomes Cancer. 2013 Aug;52(8):775-84. doi: 10.1002/gcc.22073. Epub 2013 Jun 5.

26.

BAP1 and cancer.

Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G.

Nat Rev Cancer. 2013 Mar;13(3):153-9. doi: 10.1038/nrc3459. Review.

27.
28.

SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma.

Papp G, Changchien YC, Péterfia B, Pecsenka L, Krausz T, Stricker TP, Khoor A, Donner L, Sápi Z.

Mod Pathol. 2013 Mar;26(3):393-403. doi: 10.1038/modpathol.2012.190. Epub 2012 Nov 23.

29.

Primary benign vascular tumors and tumorlike lesions of the kidney: a clinicopathologic analysis of 15 cases.

Mehta V, Ananthanarayanan V, Antic T, Krausz T, Milner J, Venkataraman G, Picken MM.

Virchows Arch. 2012 Dec;461(6):669-76. doi: 10.1007/s00428-012-1333-9. Epub 2012 Oct 23.

PMID:
23090628
30.

Pathologic quantification of connective tissue disease-associated versus idiopathic usual interstitial pneumonia.

Cipriani NA, Strek M, Noth I, Gordon IO, Charbeneau J, Krishnan JA, Krausz T, Husain AN.

Arch Pathol Lab Med. 2012 Oct;136(10):1253-8.

PMID:
23020731
31.

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.

Carbone M, Ferris LK, Baumann F, Napolitano A, Lum CA, Flores EG, Gaudino G, Powers A, Bryant-Greenwood P, Krausz T, Hyjek E, Tate R, Friedberg J, Weigel T, Pass HI, Yang H.

J Transl Med. 2012 Aug 30;10:179. doi: 10.1186/1479-5876-10-179.

32.

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.

Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG, Roggli V, Travis WD, Wick M; International Mesothelioma Interest Group.

Arch Pathol Lab Med. 2013 May;137(5):647-67. doi: 10.5858/arpa.2012-0214-OA. Epub 2012 Aug 28.

PMID:
22929121
33.

Hereditary hemochromatosis restores the virulence of plague vaccine strains.

Quenee LE, Hermanas TM, Ciletti N, Louvel H, Miller NC, Elli D, Blaylock B, Mitchell A, Schroeder J, Krausz T, Kanabrocki J, Schneewind O.

J Infect Dis. 2012 Oct 1;206(7):1050-8. doi: 10.1093/infdis/jis433. Epub 2012 Aug 14.

34.

T(2)∗ relaxation times of intraductal murine mammary cancer, invasive mammary cancer, and normal mammary gland.

Hipp E, Fan X, Jansen SA, Markiewicz EJ, Vosicky J, Newstead GM, Conzen SD, Krausz T, Karczmar GS.

Med Phys. 2012 Mar;39(3):1309-13. doi: 10.1118/1.3684950.

35.

Densely granulated murine NK cells eradicate large solid tumors.

Liu RB, Engels B, Arina A, Schreiber K, Hyjek E, Schietinger A, Binder DC, Butz E, Krausz T, Rowley DA, Jabri B, Schreiber H.

Cancer Res. 2012 Apr 15;72(8):1964-74. doi: 10.1158/0008-5472.CAN-11-3208. Epub 2012 Feb 28.

36.

Angiomatoid fibrous histiocytoma: pleomorphic variant associated with multiplication of EWSR1-CREB1 fusion gene.

Tornóczky T, Bogner B, Krausz T, Ottóffy G, Szuhai K.

Pathol Oncol Res. 2012 Apr;18(2):545-8. doi: 10.1007/s12253-011-9468-6. Epub 2011 Oct 26.

PMID:
22038502
37.

The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.

Romero IL, Lee W, Mitra AK, Gordon IO, Zhao Y, Leonhardt P, Penicka CV, Mui KL, Krausz TN, Greene GL, Lengyel E.

Gynecol Oncol. 2012 Jan;124(1):134-41. doi: 10.1016/j.ygyno.2011.08.026. Epub 2011 Oct 11.

38.

Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation.

Scanlon ST, Thomas SY, Ferreira CM, Bai L, Krausz T, Savage PB, Bendelac A.

J Exp Med. 2011 Sep 26;208(10):2113-24. doi: 10.1084/jem.20110522. Epub 2011 Sep 19.

39.

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.

Surati M, Robinson M, Nandi S, Faoro L, Demchuk C, Rolle CE, Kanteti R, Ferguson BD, Hasina R, Gangadhar TC, Salama AK, Arif Q, Kirchner C, Mendonca E, Campbell N, Limvorasak S, Villaflor V, Hensing TA, Krausz T, Vokes EE, Husain AN, Ferguson MK, Karrison TG, Salgia R.

J Clin Bioinforma. 2011 Feb 28;1(8):1-11. doi: 10.1186/2043-9113-1-8.

40.

Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.

Zillhardt M, Park SM, Romero IL, Sawada K, Montag A, Krausz T, Yamada SD, Peter ME, Lengyel E.

Clin Cancer Res. 2011 Jun 15;17(12):4042-51. doi: 10.1158/1078-0432.CCR-10-3387. Epub 2011 May 6.

41.

Nevus versus melanoma: to FISH, or not to FISH.

Song J, Mooi WJ, Petronic-Rosic V, Shea CR, Stricker T, Krausz T.

Adv Anat Pathol. 2011 May;18(3):229-34. doi: 10.1097/PAP.0b013e3182169b69. Review.

PMID:
21490440
42.

Plague in Guinea pigs and its prevention by subunit vaccines.

Quenee LE, Ciletti N, Berube B, Krausz T, Elli D, Hermanas T, Schneewind O.

Am J Pathol. 2011 Apr;178(4):1689-700. doi: 10.1016/j.ajpath.2010.12.028. Epub 2011 Mar 4.

43.

In vivo MRI of early stage mammary cancers and the normal mouse mammary gland.

Jansen SA, Conzen SD, Fan X, Markiewicz E, Krausz T, Newstead GM, Karczmar GS.

NMR Biomed. 2011 Aug;24(7):880-7. doi: 10.1002/nbm.1643. Epub 2011 Jan 25.

44.

Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.

Mackinnon AC, Tretiakova M, Henderson L, Mehta RG, Yan BC, Joseph L, Krausz T, Husain AN, Reid ME, Salgia R.

J Clin Pathol. 2011 Jan;64(1):16-24. doi: 10.1136/jcp.2010.075853. Epub 2010 Nov 2.

45.

Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.

Yan BC, Gong C, Song J, Krausz T, Tretiakova M, Hyjek E, Al-Ahmadie H, Alves V, Xiao SY, Anders RA, Hart JA.

Am J Surg Pathol. 2010 Aug;34(8):1147-54. doi: 10.1097/PAS.0b013e3181e5dffa.

46.

Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.

Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, Bianchi ME, Carbone M.

Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12611-6. doi: 10.1073/pnas.1006542107. Epub 2010 Jun 28.

47.

Protocol for the examination of specimens from patients with tumors of soft tissue.

Rubin BP, Cooper K, Fletcher CD, Folpe AL, Gannon FH, Hunt JL, Lazar AJ, Montag AG, Peabody TD, Pollock RE, Reith JD, Qualman SJ, Rosenberg AE, Weiss SW, Krausz T; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Apr;134(4):e31-9. doi: 10.1043/1543-2165-134.4.e31. No abstract available.

PMID:
20367297
48.

Protocol for the examination of specimens from patients with tumors of bone.

Rubin BP, Antonescu CR, Gannon FH, Hunt JL, Inwards CY, Klein MJ, Kneisl JS, Montag AG, Peabody TD, Reith JD, Rosenberg AE, Krausz T; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Apr;134(4):e1-7. doi: 10.1043/1543-2165-134.4.e1. No abstract available.

PMID:
20367293
50.

Protocol for the examination of specimens from patients with gastrointestinal stromal tumor.

Rubin BP, Blanke CD, Demetri GD, Dematteo RP, Fletcher CD, Goldblum JR, Lasota J, Lazar A, Maki RG, Miettinen M, Noffsinger A, Washington MK, Krausz T; Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Feb;134(2):165-70. doi: 10.1043/1543-2165-134.2.165. No abstract available.

PMID:
20121601

Supplemental Content

Loading ...
Support Center